Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Bristol-Myers Squibb Company recalls Opdualag (nivolumab and relatlimab-rmbw) injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility.
Products
  • Opdualag (nivolumab and relatlimab-rmbw) injection
Company
Bristol-Myers Squibb Company
Where it was sold

Nationwide in the USA

Nationwide

Units affected
12,778 total vials
About this recall
Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11